Document is current
Any future updates will be listed below
-
Authors
Oliveira, T.
Brown, J. https://orcid.org/0000-0003-1910-788X
Juby, A. G.
Schneider, P.
Wani, R. J. https://orcid.org/0000-0002-2422-7758
Packalen, M.
Avcil, S.
Li, S.
Farris, M.
Graves, E.
McMullen, S. https://orcid.org/0000-0001-7852-9930
Kendler, D. L.
-
Funding
Funding for this research was provided by:
Amgen Canada
- License Information
-
More Information
Article History
Received: 7 March 2022
Accepted: 13 June 2022
First Online: 3 August 2022
Declarations
:
: Ethics approval was obtained from the Health Research Ethics Board of Alberta – Community Health Committee (HREBA-CHC).
: N/A.
: N/A.
: SM, EG, MSF, and SL are employed by Medlior, which received funding for the study from Amgen Canada. TO, RW, MP, and SA are employed by Amgen Canada who funded this study and hold Amgen stock. DLK reports research support from Amgen, Astellas, AstraZeneca, and Eli Lilly, consulting fees from Amgen, Eli Lilly, Merck, and Pfizer, and is on the speakers’ bureau for Amgen, Eli Lilly, and GSK. JPB reports research support from Mereo BioPharma, Radius Health and Servier, consulting fees from Amgen, Paladin Labs Inc., Pfizer, and Servier, and is on the speakers’ bureau for Amgen. AGJ has participated in Advisory Boards for Amgen Canada and Paladin Labs Inc, and is on the speaker bureau for Amgen. PS reports research support from Johnson & Johnson, Smith & Nephew, and DePuy Synthes and has participated on Advisory Boards for Amgen.
